Burning Rock Biotech (BNR) Notes Payables (2019 - 2025)

Burning Rock Biotech's Notes Payables history runs 8 years deep, the most recent figure standing at $86000.0 for Q1 2026.

• In Q1 2026, Notes Payables rose 4.88% year-over-year to $86000.0; the TTM figure through Mar 2026 stood at $86000.0 (up 4.88% YoY), while the FY2025 annual figure was $85000.0, up 4.94% from the prior year.
• Notes Payables for Q1 2026 stood at $86000.0, up from $83467.6 in the prior quarter.
• The five-year high for Notes Payables was $354000.0 in Q2 2022, with the low at $28000.0 in Q3 2025.
• The 5-year median for Notes Payables is $153000.0 (2022), against an average of $137861.2.
• The sharpest annual moves came in 2023 and 2025: Notes Payables surged 187.72% in 2023, then plunged 65.43% in 2025.
• Burning Rock Biotech's Notes Payables stood at $253509.2 in 2022, then tumbled by 34.42% to $166248.2 in 2023, then slumped by 50.43% to $82415.7 in 2024, then increased by 1.28% to $83467.6 in 2025, then rose by 3.03% to $86000.0 in 2026.
• Business Quant data shows BNR's Notes Payables at $86000.0 in Q1 2026, $83467.6 in Q4 2025, and $28000.0 in Q3 2025.